Frederick K. Askari

1.5k total citations
26 papers, 1.1k citations indexed

About

Frederick K. Askari is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Nutrition and Dietetics. According to data from OpenAlex, Frederick K. Askari has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Health, Toxicology and Mutagenesis and 5 papers in Nutrition and Dietetics. Recurrent topics in Frederick K. Askari's work include Trace Elements in Health (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and RNA Interference and Gene Delivery (3 papers). Frederick K. Askari is often cited by papers focused on Trace Elements in Health (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and RNA Interference and Gene Delivery (3 papers). Frederick K. Askari collaborates with scholars based in United States, Poland and Austria. Frederick K. Askari's co-authors include Robert J. Fontana, Hari S. Conjeevaram, Anna S. Lok, Jorge A. Marrero, Grace L. Su, W. Michael McDonnell, James M. Wilson, Nonthalee Pausawasdi, Andrea Todisco and Saravanan Ramamoorthy and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Frederick K. Askari

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederick K. Askari United States 12 517 427 241 234 144 26 1.1k
Hans Nordlinder Sweden 18 320 0.6× 405 0.9× 394 1.6× 137 0.6× 190 1.3× 40 1.3k
Cristiana Bulato Italy 20 358 0.7× 329 0.8× 395 1.6× 167 0.7× 183 1.3× 47 1.4k
Akihiko Ohno Japan 18 548 1.1× 290 0.7× 216 0.9× 394 1.7× 96 0.7× 41 963
Elmar Siewert Germany 10 422 0.8× 410 1.0× 124 0.5× 185 0.8× 233 1.6× 20 942
Toshifumi Ito Japan 18 193 0.4× 168 0.4× 653 2.7× 339 1.4× 280 1.9× 44 1.2k
Xiaojuan Ou China 17 558 1.1× 642 1.5× 87 0.4× 183 0.8× 73 0.5× 93 939
J Petrtýl Czechia 15 161 0.3× 157 0.4× 98 0.4× 176 0.8× 77 0.5× 51 639
Yasushi Seo Japan 17 379 0.7× 468 1.1× 260 1.1× 107 0.5× 156 1.1× 44 1.1k
Takenari Yamanaka Japan 19 184 0.4× 282 0.7× 741 3.1× 153 0.7× 305 2.1× 45 1.3k
K. Weinbren United Kingdom 19 460 0.9× 289 0.7× 141 0.6× 418 1.8× 202 1.4× 42 1.1k

Countries citing papers authored by Frederick K. Askari

Since Specialization
Citations

This map shows the geographic impact of Frederick K. Askari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick K. Askari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick K. Askari more than expected).

Fields of papers citing papers by Frederick K. Askari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick K. Askari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick K. Askari. The network helps show where Frederick K. Askari may publish in the future.

Co-authorship network of co-authors of Frederick K. Askari

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick K. Askari. A scholar is included among the top collaborators of Frederick K. Askari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick K. Askari. Frederick K. Askari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sankoh, Serap, et al.. (2022). eP140: A novel, double-blind placebo-controlled seamless phase 1/2/3 AAV9 gene therapy study for Wilson disease. Genetics in Medicine. 24(3). S86–S86. 2 indexed citations
2.
Weiss, Karl Heinz, Frederick K. Askari, Anna Członkowska, et al.. (2017). Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study. ˜The œLancet. Gastroenterology & hepatology. 2(12). 869–876. 107 indexed citations
3.
Houchens, Nathan, Gurpreet Dhaliwal, Frederick K. Askari, Benjamin Kim, & Sanjay Saint. (2013). The Essential Element. New England Journal of Medicine. 368(14). 1345–1351. 1 indexed citations
4.
Sharma, Pratima, Jorge A. Marrero, Robert J. Fontana, et al.. (2007). Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence. Liver Transplantation. 13(8). 1100–1108. 69 indexed citations
5.
Marrero, Jorge A., Robert J. Fontana, Frederick K. Askari, et al.. (2005). Prognosis of hepatocellular carcinoma. Hepatology. 41(4). 707–715. 466 indexed citations
6.
Stepan, Vinzenz, Saravanan Ramamoorthy, Nonthalee Pausawasdi, et al.. (2004). Role of small GTP binding proteins in the growth-promoting and antiapoptotic actions of gastrin. American Journal of Physiology-Gastrointestinal and Liver Physiology. 287(3). G715–G725. 27 indexed citations
7.
Pausawasdi, Nonthalee, Saravanan Ramamoorthy, Leslie J. Crofford, Frederick K. Askari, & Andrea Todisco. (2002). Regulation and function of COX-2 gene expression in isolated gastric parietal cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 282(6). G1069–G1078. 11 indexed citations
8.
Todisco, Andrea, Nonthalee Pausawasdi, Saravanan Ramamoorthy, et al.. (2001). Functional Role of Protein Kinase B/Akt in Gastric Acid Secretion. Journal of Biological Chemistry. 276(49). 46436–46444. 17 indexed citations
9.
Todisco, Andrea, et al.. (2001). Molecular mechanisms for the antiapoptotic action of gastrin. American Journal of Physiology-Gastrointestinal and Liver Physiology. 280(2). G298–G307. 73 indexed citations
10.
Kometiani, P. A., Amir Askari, Jiang Liu, Zijian Xie, & Frederick K. Askari. (2001). Downregulation of cardiac myocyte Na+-K+-ATPase by adenovirus-mediated expression of an α-subunit fragment. American Journal of Physiology-Heart and Circulatory Physiology. 280(3). H1415–H1421. 8 indexed citations
11.
12.
Askari, Frederick K. & W. Michael McDonnell. (1996). Antisense-Oligonucleotide Therapy. New England Journal of Medicine. 334(5). 316–318. 99 indexed citations
13.
McDonnell, W. Michael, et al.. (1996). Identification of bilirubin UDP-GTs in the human alimentary tract in accordance with the gut as a putative metabolic organ. Biochemical Pharmacology. 51(4). 483–488. 29 indexed citations
14.
Askari, Frederick K., et al.. (1995). Retrovirus-mediated expression of HUG Br1 in Crigler-Najjar syndrome type I human fibroblasts and correction of the genetic defect in Gunn rat hepatocytes.. PubMed. 2(3). 203–8. 10 indexed citations
15.
Askari, Frederick K.. (1995). Molecular mechanism of hepatocellular injury in alpha1 antitrypsin deficiency. Hepatology. 21(6). 1745–1747. 2 indexed citations
16.
17.
18.
Askari, Frederick K. & James M. Wilson. (1992). Provocative Gene Therapy Strategy for the Treatment of Hepatocellular Carcinoma. Hepatology. 16(1). 273–274. 4 indexed citations
19.
Bunnell, Bruce A., Frederick K. Askari, & James M. Wilson. (1992). Targeted delivery of antisense oligonucleotides by molecular conjugates. Somatic Cell and Molecular Genetics. 18(6). 559–569. 45 indexed citations
20.
Fiamengo, Steven A., Frederick K. Askari, Gregg S. Hartman, & Walter F. Riker. (1986). NEUROMUSCULAR AND CARDIOVASCULAR EFFECTS OF RANITIDINE HCl. Anesthesiology. 65(Supplement 3A). A298–A298. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans Nordlinder Breakdown of academic impact, for papers by Cristiana Bulato Breakdown of academic impact, for papers by Akihiko Ohno Breakdown of academic impact, for papers by Elmar Siewert Breakdown of academic impact, for papers by Toshifumi Ito Breakdown of academic impact, for papers by Xiaojuan Ou Breakdown of academic impact, for papers by J Petrtýl Breakdown of academic impact, for papers by Yasushi Seo Breakdown of academic impact, for papers by Takenari Yamanaka Breakdown of academic impact, for papers by K. Weinbren
Rankless by CCL
2026